References
- Ricklin D, Lambris JD. Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol. 2013;190:3831–3838. doi:10.4049/jimmunol.1203487
- Shen Y, Lue L, Yang L, et al. Complement activation by neurofibrillary tangles in Alzheimer’s disease. Neurosci Lett. 2001;305:165–168. doi:10.1016/S0304-3940(01)01842-0
- Veerhuis R, Nielsen HM, Tenner AJ. Complement in the brain. Mol Immunol. 2011;48(14):1592–1603. doi:10.1016/j.molimm.2011.04.003
- Fu S, Yao Y, Lv F, Zhang F, Zhao Y, Luan F. Associations of immunological factors with metabolic syndrome and its characteristic elements in Chinese centenarians. J Transl Med. 2018;16(1):315. doi:10.1186/s12967-018-1691-4
- Drew DA, Weiner DE, Sarnak MJ. Cognitive Impairment in CKD: pathophysiology, management, and prevention. Am J Kidney Dis. 2019;74(6):782–790. doi:10.1053/j.ajkd.2019.05.017
- Murray AM, Tupper DE, Knopman DS, et al. Cognitive impairment in hemodialysis patients is common. Neurology. 2006;67(2):216–223. doi:10.1212/01.wnl.0000225182.15532.40
- Nho K, Kueider-Paisley A, Ahmad S, et al. Association of altered liver enzymes with Alzheimer disease diagnosis, cognition, neuroimaging measures, and cerebrospinal fluid biomarkers. JAMA Netw Open. 2019;2(7):e197978. doi:10.1001/jamanetworkopen.2019.7978
- Murman DL. The Impact of Age on Cognition. Semin Hear. 2015;36(3):111–121. doi:10.1055/s-0035-1555115
- Fu S, Hu J, Chen X, et al. Mutant single nucleotide polymorphism rs189037 in ataxia-telangiectasia mutated gene is significantly associated with ventricular wall thickness and human lifespan. Front Cardiovasc Med. 2021;8:658908. doi:10.3389/fcvm.2021.658908
- Fu S, Yu H, Li Y, et al. Multiple measures of mineral metabolism were associated with renal function in Chinese centenarians: a cross-sectional study. Front Med. 2020;7:120. doi:10.3389/fmed.2020.00120
- Ibrahim NM, Shohaimi S, Chong H-T, et al. Validation study of the mini-mental state examination in a Malay-speaking elderly population in Malaysia. Dement Geriatr Cogn Disord. 2009;27:247e53. doi:10.1159/000203888
- Xiu S, Zheng Z, Guan S, Zhang J, Ma J, Chan P. Serum uric acid and impaired cognitive function in community-dwelling elderly in Beijing. Neurosci Lett. 2017;637:182e7. doi:10.1016/j.neulet.2016.11.013
- Rabins P, Schwartz S, Tschanz JA, Corcoran C, Lyketsos C. Risk factors for severe dementia from a population-based sample of incident Alzheimer’s disease: the Cache County Dementia Progression Study. Alzheimers Dement. 2011;7:S356. doi:10.1016/j.jalz.2011.05.1031
- Kliegel M, Zimprich D, Rott C. Life-long intellectual activities mediate the predictive effect of early education on cognitive impairment in centenarians: a retrospective study. Aging Ment Health. 2004;8:430e7. doi:10.1080/13607860410001725072
- Molander L, Gustafson Y, Lövheim H. Longitudinal associations between blood pressure and dementia in the very old. Dement Geriatr Cogn Disord. 2010;30(3):269–276. doi:10.1159/000320252
- Launer LJ, Ross GW, Petrovitch H, et al. Midlife blood pressure and dementia: the Honolulu-Asia Aging Study. Neurobiol Aging. 2000;21:49–55. doi:10.1016/S0197-4580(00)00096-8
- Ou YN, Tan CC, Shen XN, et al. Blood pressure and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 209 prospective studies. Hypertension. 2020;76(1):217–225. doi:10.1161/HYPERTENSIONAHA.120.14993
- Mossello E. Hypertension, hypotension, longevity and dementia. Monaldi Arch Chest Dis. 2020;90(4). doi:10.4081/monaldi.2020.1674
- Moss MB, Jonak E. Cerebrovascular disease and dementia: a primate model of hypertension and cognition. Alzheimers Dement. 2007;3(2 Suppl):S6–S15. doi:10.1016/j.jalz.2007.01.002
- Novak V, Hajjar I. The relationship between blood pressure and cognitive function. Nat Rev Cardiol. 2010;7(12):686–698. doi:10.1038/nrcardio.2010.161
- Sarnak MJ, Tighiouart H, Scott TM, et al. Frequency of and risk factors for poor cognitive performance in hemodialysis patients. Neurology. 2013;80(5):471–480. doi:10.1212/WNL.0b013e31827f0f7f
- Griva K, Stygall J, Hankins M, Davenport A, Harrison M, Newman SP. Cognitive impairment and 7-year mortality in dialysis patients. Am J Kidney Dis. 2010;56(4):693–703. doi:10.1053/j.ajkd.2010.07.003
- Madero M, Gul A, Sarnak MJ. Cognitive function in chronic kidney disease. Semin Dial. 2008;21:29–37. doi:10.1111/j.1525-139X.2007.00384.x
- Murray AM. Cognitive impairment in the aging and chronic kidney disease populations: an occult burden. Adv Chronic Kidney Dis. 2008;15:123–132. doi:10.1053/j.ackd.2008.01.010
- Murray AM, Knopman DS. Cognitive impairment in CKD: no longer an occult burden. Am J Kidney Dis. 2010;56:615–618. doi:10.1053/j.ajkd.2010.08.003
- Elias MF, Dore GA, Davey A. Kidney disease and cognitive function. Contrib Nephrol. 2013;179:42–57.
- Richard EL, McEvoy LK, Oren E, et al. Markers of kidney function and longitudinal cognitive ability among older community-dwelling adults: the Rancho Bernardo Study. J Alzheimers Dis. 2021;83(1):319–331. doi:10.3233/JAD-201605
- Bai K, Pan Y, Lu F, Zhao Y, Wang J, Zhang L. Kidney function and cognitive decline in an oldest-old Chinese population. Clin Interv Aging. 2017;12:1049–1054. doi:10.2147/CIA.S134205
- Stratta P, Gravellone L, Cena T, et al. Renal outcome and monoclonal immunoglobulin deposition disease in 289 old patients with blood cell dyscrasias: a single center experience. Crit Rev Oncol Hematol. 2011;79(1):31–42. doi:10.1016/j.critrevonc.2010.05.001
- Popović M, Tavćar R, Glavac D, et al. Light chain deposition disease restricted to the brain: the first case report. Hum Pathol. 2007;38(1):179–184. doi:10.1016/j.humpath.2006.07.010
- Nadeau SE. Neurologic manifestations of connective tissue disease. Neurol Clin. 2002;20:151–178. doi:10.1016/S0733-8619(03)00057-4
- Matsui H, Udaka F, Oda M, et al. Encephalopathy and severe neuropathy due to probable systemic vasculitis as an initial manifestation of mixed connective tissue disease. Neurol India. 2006;54(1):83–85. doi:10.4103/0028-3886.24716
- Ortega-Hernandez OD, Shoenfeld Y. Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment. Best Pract Res Clin Rheumatol. 2012;26(1):61–72. doi:10.1016/j.berh.2012.01.009